Overcoming the barriers to HPV vaccination in high-risk populations in the U.S.: A Society of Gynecologic Oncology (SGO) Review.

Autor: Teoh D; University of Minnesota, Minneapolis, MN, USA., Hill EK; University of Iowa Hospitals and Clinics, Iowa City, IA, USA., Goldsberry W; University of Alabama, Birmingham, AL, USA., Levine L; University of Texas at Rio Grande Valley, Edinburg, TX, USA., Novetsky A; Rutgers Health, Newark, NJ, USA., Downs L Jr; Park Nicolett Health Services, St. Louis Park, MN, USA. Electronic address: levidowns008@gmail.com.
Jazyk: angličtina
Zdroj: Gynecologic oncology [Gynecol Oncol] 2021 Apr; Vol. 161 (1), pp. 228-235. Date of Electronic Publication: 2021 Mar 09.
DOI: 10.1016/j.ygyno.2021.01.023
Abstrakt: Competing Interests: Declaration of Competing Interest Dr. Downs reports personal fees from Astra Zeneca, outside the submitted work. Dr. Novetsky reports personal fees from CSATS inc., grants from Roche, outside the submitted work. Dr. Teoh reports grants from Acelity, other from Tesaro, outside the submitted work. All other authors report no conflicts of interest.
Databáze: MEDLINE